×

Hedge Funds John Paulson

  • A Reuters analysis of filings with the U.S. Securities and Exchange Commission showed that Coatue Management, Omega Advisors, Third Point, Tiger Global Management, Appaloosa Management, Paulson& Co, Soros Fund Management and Greenlight Capital in aggregate slashed 16 stakes, sold two stakes, increased six stakes, opened two new stakes, and maintained two...

  • Aug 10- Valeant Pharmaceuticals International Inc investor John Paulson trimmed his stake in the Canadian drugmaker but said he remains fully supportive of the company's leadership. New York- based hedge fund Paulson& Co cut its stake to 6 percent from 6.3 percent, reported in June, due to rebalancing of its portfolios based on asset flows.

  • John Paulson

    New York-based hedge fund Paulson & Co. on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals.

  • TORONTO, June 26- Canada's main stock index edged lower on Monday in cautious trading ahead of the end of the second quarter, as declines in the heavyweight resource and financial groups offset gains for consumer-related shares. The Toronto Stock Exchange's S&P/TSX composite index fell 3.54 points, or 0.02 percent, to 15,316.02. "No one is going to stick their...

  • June 26- New York- based hedge fund Paulson& Co on Monday reported a 6.3 percent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc. The disclosure comes a week after billionaire investor John Paulson, whose hedge fund firm is the biggest owner of Valeant, joined the company's board as it restructures to repay debt.

  • June 26- New York- based hedge fund Paulson& Co on Monday reported a 6.3 percent stake in Canada's Valeant Pharmaceuticals International Inc,. Paulson, who is Valeant's biggest stakeholder, had a 5.68 percent stake in the company as of March 31, according to Thomson Reuters data. Last week, billionaire investor John Paulson, joined the ailing drug company's board as...

  • June 26- New York- based hedge fund Paulson& Co on Monday reported a 6.3 percent stake in Canada's Valeant Pharmaceuticals International Inc,. Paulson, who is Valeant's biggest stakeholder, had a 5.68 percent stake in the company as of March 31, according to Thomson Reuters data. Last week, billionaire investor John Paulson, joined the ailing drug company's board as...

  • TORONTO, June 26- Canada's main stock index fell on Monday as declines in heavyweight sectors such as energy and materials outweighed moderate gains in a number of other groups. Agnico Eagle Mines Ltd slumped 2 percent to C $62.17, while Goldcorp Inc fell 1.2 percent to C $18.07. At 10:41 a.m. ET, the Toronto Stock Exchange's S&P/TSX composite index fell 36.41...

  • OTTAWA, June 19- Canada's main stock index was lifted by shares of financial firms on Monday, while energy companies got a boost as oil prices steadied after coming under pressure over the past month. Royal Bank of Canada was the biggest gainer on the index, up 1.0 percent at C $94.47, followed by Toronto-Dominion Bank, which advanced 1.0 percent to C $65.7.

  • June 19- Billionaire investor John Paulson, whose hedge fund firm is the biggest owner of Valeant Pharmaceuticals International Inc shares, on Monday joined the ailing drug company's board as it restructures to repay debt. Investors appeared to see Paulson's becoming a director as a vote of confidence in Valeant, sending its U.S.-listed shares up 5.1. percent...

  • John Paulson

    Hedge fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals.

  • Hedge-fund manager John Paulson

    Senior executives are said to be exiting hedge fund Paulson & Co as some portfolios suffer losses and assets dip.

  • June 9- Portfolio manager Sheru Chowdhry is expected to leave Paulson& Co, two sources said on Friday, signaling a quickening pace of departures at the hedge fund as its assets have shrunk and some of its portfolios have suffered losses. Executives T. Michael Johnson, Natalie Oelkers and Claudio Macchetto have also left or are expected to soon leave the New York...

  • NEW YORK, May 15- Paulson& Co held its stake steady in the world's biggest gold exchange-traded fund while Soros Fund Management stayed out of the precious metal in the first quarter of 2017, when bullion prices rallied to 3-1/ 2- month highs, a filing showed on Monday. New York- based Paulson& Co, led by longtime gold bull John Paulson, kept its stake unchanged in SPDR...

  • NEW YORK, May 15- Paulson& Co held its stake steady in the world's biggest gold exchange-traded fund while Soros Fund Management stayed out of the precious metal in the first quarter of 2017, when bullion prices rallied to 3-1/ 2- month highs, a filing showed on Monday. New York- based Paulson& Co, led by longtime gold bull John Paulson, kept its stake unchanged in SPDR...

  • NEW YORK, May 15- Paulson& Co held its shares unchanged in the world's biggest gold exchange-traded fund in the first quarter of 2017, when gold prices rallied nearly 10 percent, a 13 F filing with the U.S. Securities and Exchange Commission showed on Monday. New York- based Paulson& Co, led by longtime gold bull John Paulson, held its stake in SPDR Gold Trust steady at...

  • Chief Executive Officer Peter Hancock said on March 9 he would depart once the board found a replacement, citing a lack of confidence among directors and investors. Chairman Douglas Steenland has said AIG's board remains committed to the existing turnaround effort. "We need to know" about the impending choice of CEO, said Sandler O'Neill analyst Paul Newsome.

  • Chief Executive Officer Peter Hancock said on March 9 he would depart once the board found a replacement, citing a lack of confidence among directors and investors. Chairman Douglas Steenland has said AIG's board remains committed to the existing turnaround effort. "We need to know" about the impending choice of CEO, said Sandler O'Neill analyst Paul Newsome.

  • Chief Executive Officer Peter Hancock announced on March 9 that he would depart once the board found a replacement, citing a lack of confidence among directors and investors. Chairman Douglas Steenland has said that AIG's board remains committed to the existing turnaround effort, but analysts are doubtful over whether a new CEO would carry out Hancock's...

  • Chief Executive Officer Peter Hancock announced on March 9 that he would depart once the board found a replacement, citing a lack of confidence among directors and investors. Chairman Douglas Steenland has said that AIG's board remains committed to the existing turnaround effort, but analysts are doubtful over whether a new CEO would carry out Hancock's...